Evidence map›Paper›PMID 38779114›Full record

ArticlePNAS nexus2024

Tensor modeling of MRSA bacteremia cytokine and transcriptional patterns reveals coordinated, outcome-associated immunological programs.

Jackson L Chin, Zhixin Cyrillus Tan, Liana C Chan, Felicia Ruffin, Rajesh Parmar, Richard Ahn, Scott D Taylor, Arnold S Bayer, Alexander Hoffmann, Vance G Fowler and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PNAS nexus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jackson L ChinDepartment of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90024, USA.ORCID https://orcid.org/0000-0001-6124-9625
Zhixin Cyrillus TanBioinformatics Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA 90024, USA.
Liana C ChanThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.ORCID https://orcid.org/0000-0003-2567-4418
Felicia RuffinDivision of Infectious Diseases, Duke University School of Medicine, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0003-2176-6462
Rajesh ParmarDepartment of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.ORCID https://orcid.org/0000-0002-6122-4345
Richard AhnInstitute for Quantitative and Computational Biosciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Scott D TaylorDepartment of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90024, USA.
Arnold S BayerThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Alexander HoffmannInstitute for Quantitative and Computational Biosciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.ORCID https://orcid.org/0000-0002-5607-3845
Vance G FowlerDivision of Infectious Diseases, Duke University School of Medicine, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0002-8048-0897
Elaine F ReedDepartment of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.ORCID https://orcid.org/0000-0002-3524-545X
Michael R YeamanThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.ORCID https://orcid.org/0000-0002-9468-5252
Aaron S MeyerDepartment of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90024, USA.ORCID https://orcid.org/0000-0003-4513-1840
with the MRSA Systems Immunobiology Group

Funding

The Effect of Nanoparticle Encapsulated Resveratrol on Treatment of PeriodontitisKL2TR001882 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2016 to 2026
$13.1M
Systems Epigenomics of Persistent Bloodstream InfectionU19AI172713 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI Monica Cappelletti · 2023 to 2026
$11.6M
Project 3: Mapping the Evolution of Chronic Transplant Injury in the Context of CMV InfectionU19AI128913 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ELASHOFF, DAVID · 2017 to 2021
$11.2M
Systems Immunolobiology of Antibiotic-Persistent MRSA InfectionU01AI124319 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2020
$10.1M
Host Susceptibility to S. aureusR01AI068804 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G. · 2007 to 2016
$6.9M
Mitigating Resistance & Virulence in MRSAR33AI111661 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2018
$1.2M
NCATS NIH HHS KL2 TR001882NIAID NIH HHS R01 AI068804NIAID NIH HHS R33 AI111661NIAID NIH HHS U01 AI124319NIAID NIH HHS U19 AI128913NIAID NIH HHS U19 AI172713
6 · The paper itself

Abstract

Methicillin-resistant

Indexed as

CD4+ T cellsgranulocytesMRSApersistencetensor factorization

Identifiers

PMID38779114
PMCPMC11109816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.